BUY Mankind Pharma Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·23 Sept · today
Past week's volume 1.7× the 30-day average
Technicals · volume·23 Sept · today
Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend
NewsLivemint·22 Sept · yesterday
Mankind Pharma shares get an upgrade from Kotak; Price target among top five on the street
NewsCnbc-Tv18·22 Sept · yesterday
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·22 Sept · yesterday
Mankind Pharma Gets 68.21 ESG Rating From Niche99 In Leader Category
NewsGoogle News·16 Sept · 1w ago
Mankind Pharma to attend three investor conferences in September 2026
NewsGoogle News·11 Sept · 2w ago
Mankind Pharma to meet investors in Mumbai on June 1-2
NewsGoogle News·11 Sept · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.